Centro Hospitalar de Lisboa Central, E.P.E. - Hospital de Santo Antonio dos Capuchos

Lisbon 1169-050

1 studies enrolling now · 2 studies all time

What they study most

Indolent Systemic Mastocytosis, Locally Advanced or Unresectable Metastatic Breast Cancer, Smoldering Systemic Mastocytosis, Stage IV Breast Cancer

Studies at this site

• (HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis — Recruiting now
• Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer Who Have Received Endocrine Therapy — Running, not enrolling